Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

ReutersJun 16, 2025 11:42 PM

June 16 (Reuters) - Eli Lilly LLY.N is in advanced talks to acquire gene editing startup Verve Therapeutics VERV.O for up to $1.3 billion, the Financial Times reported on Monday, citing people familiar with the matter.

Reuters could not immediately verify the report.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Deep Analysis 48 Hours Before Microsoft Earnings: OpenAI Agreement Restructuring Implemented, Three Variables of Azure, Copilot, and Capital Expenditure Determine MSFT Valuation Recovery Path

Microsoft released its FY26 Q3 earnings on April 29. This article provides an in-depth analysis of the impact of the OpenAI agreement restructuring, examining three key metrics—Azure growth, a 3.3% Copilot penetration rate, and $110 billion in capital expenditure—to determine whether MSFT’s forward P/E of 22x offers a long-term positioning opportunity.

Nvidia Shares Hit Record High, Market Cap Tops $526 Trillion, How Much Higher Can It Go Amid AI Capex Boom?

TradingKey - On April 27, Eastern Time, driven by rising expectations for AI capital expenditure, Nvidia’s share price continued its rally from Friday, closing up 4% at a record high of $216.83, with its market capitalization reaching $5.26 trillion.

SEC, CFTC and White House ‘Triple Resonance,’ Can Bitcoin Break $80,000 During the CLARITY Act Window?

The SEC, CFTC, and the White House are collectively advancing the U.S. crypto regulatory environment, and Bitcoin prices are expected to further strengthen.

Microsoft 2026 Q3 Earnings Preview: Can Azure’s Growth Momentum Keep Up With Massive AI Capital Spending?

TradingKey - Microsoft (MSFT) is scheduled to release its Q3 FY2026 earnings report after the market close on April 29, ET. As one of the most proactive tech giants in advancing global AI strategies, this report is regarded as a key indicator for evaluating the large-scale monetization of AI technology and the growth resilience of its cloud business.

Citi Raises Brent Crude Forecast to $150: Strait of Hormuz Risks Brew, How High Can Oil Prices Rise?

TradingKey - On April 26, Eastern Time, Citigroup raised its 2026 Brent crude oil price forecast to $150. Citing the deadlock in U.S.-Iran negotiations and the resulting persistent blockade of the Strait of Hormuz, Citi believes the situation in the Middle East has shifted from a short-term risk to a structural variable that could continuously disrupt global supply.

Featured Tools